Try our beta test site
608 studies found for:    Open Studies | ovarian cancer
Show Display Options
Rank Status Study
1 Recruiting Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ)
Condition: Ovarian Cancer
Intervention: Drug: pazopanib in combination with weekly topotecan
2 Recruiting A Study of Pembrolizumab With Standard Treatment in Patients With Recurrent Platinum-resistant Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Pembrolizumab;   Drug: Gemcitabine;   Drug: Cisplatin
3 Recruiting Writing About Experiences With Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Behavioral: Writing about ovarian cancer
4 Recruiting Dual PETOvac - Dual Time PET/CT in the Preoperative Assessment of Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Other: PET/CT(3hours]
5 Recruiting Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Procedure: ovarian cancer surgery
6 Recruiting Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: OMP-54F28, Paclitaxel and Carboplatin
7 Not yet recruiting Treatment for Malignant Ovarian Cancer: Laparoscopy vs Laparotomy
Condition: Ovarian Cancer
Interventions: Procedure: Laparoscopy;   Procedure: Laparotomy
8 Recruiting Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study
Condition: Ovarian Cancer
Intervention:
9 Recruiting Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Apatinib;   Drug: Etoposide
10 Recruiting The Analyses of Treatment Efficacy and Cost-effectiveness in Early-staged Ovarian Cancer Patients
Condition: Ovarian Cancer
Intervention:
11 Recruiting Cabazitaxel vs. Tocotrienol in Patients With Recurrent Ovarian Cancer After Failure of Standard Therapy.
Condition: Ovarian Cancer
Interventions: Drug: Cabazitaxel;   Drug: Tocotrienol
12 Recruiting Study of Predictive Factors of Chemoresistance in Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Procedure: Cancer treatment
13 Recruiting EWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Paclitaxel + Carboplatin every 3 weeks;   Drug: Carboplatin monotherapy every 3 weeks;   Drug: Weekly Paclitaxel and Carboplatin
14 Recruiting Mesenchymal Stem Cells (MSC) for Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Genetic: MSC-INFβ;   Behavioral: Questionnaires
15 Recruiting Efficacy and Safety Study of Cediranib in Combination With Olaparib in Patients With Recurrent Platinum-Resistant Ovarian Cancer
Condition: Recurrent Platinum Resistant Ovarian Cancer
Intervention: Drug: cediranib and olaparib
16 Recruiting Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
Condition: Ovarian Cancer
Intervention: Behavioral: Questionnaire
17 Recruiting Quality of Life Associated With a Low-Risk Screening Program for Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Behavioral: Questionnaire
18 Recruiting Safety and Efficacy Study of Nuc-1031 and Carboplatin Combination to Treat Recurrent Ovarian Cancer
Condition: Recurrent Ovarian Cancer
Intervention: Drug: Nuc-1031 and Carboplatin
19 Recruiting C-PATROL - Non-interventional Study (NIS) to Collect Clinical and Patient Reported Outcome Data in an Olaparib Treated BRCAm+ PSR Ovarian Cancer Population
Condition: Ovarian Cancer, Hereditary Ovarian Cancer Syndrome
Intervention:
20 Recruiting CT Antigen TCR-redirected T Cells for Ovarian Cancer.
Condition: Ovarian Cancer
Intervention: Biological: NYESO-1c259 T cells

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.